• Nenhum resultado encontrado

[PDF] Top 20 Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly.

Has 10000 "Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly." found on our website. Below are the top 20 most common "Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly.".

Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly.

Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly.

... diagnosed patients with acromegaly were referred to Chonnam National University Hwasun Hospital between April 2004 and April ...two patients who presented with inoperable tumors, the ... See full document

8

Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins

Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins

... BTG is well recognized (Hanumanthappa et al., 2012). In Gandolfi et ...detection of unsuspected PTC in 14% of BTG patients after postoperative histopathologic examination, and ... See full document

17

Seven-year follow-up of a juvenile female with papillary thyroid carcinoma with poor outcome, BRAF mutation and loss of expression of iodine-metabolizing genes

Seven-year follow-up of a juvenile female with papillary thyroid carcinoma with poor outcome, BRAF mutation and loss of expression of iodine-metabolizing genes

... investigated BRAF mutational status in metastatic and non-metastatic papillary thyroid carcinomas ...have not only found an associa- tion between BRAF-mutation and a more ... See full document

4

Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter

Preoperatively undiagnosed papillary thyroid carcinoma in patients thyroidectomized for benign multinodular goiter

... rate is comparable to rates from other European countries, including Belgium, Italy (25,30,33) and Greece ...vicinity of our medical center and residence of patients to three nuclear plant ... See full document

10

Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

... (PCLND) is frequently performed in patients with clinically negative central lymph nodes ...applied in patients with T1 and T2 ...benefits of PCLND for CN0 ... See full document

17

Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.

Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.

... percentage of BRAF(V600E) alleles defines a PTC molecular subtype and predicts a poorer disease outcome [23,24] and analysis of BRAF mutations by pyrosequencing has recently been demonstrated ... See full document

10

miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.

miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.

... miR-26a is down- regulated in PTC [4,5,6,7,8], to date no data have been available regarding the mechanism of miR-26a in this ...growth in an EZH2-dependent manner in ... See full document

11

mTOR pathway  in BRAF mutated papillary thyroid carcinoma.

mTOR pathway in BRAF mutated papillary thyroid carcinoma.

... up-regulation of mTOR pathway (25), suggesting that this effect is not tumor-type ...higher in cPTC, although with a preferential cytoplasmic localization. In fact, a decrease ... See full document

11

Arq Bras Endocrinol Metab  vol.53 número9

Arq Bras Endocrinol Metab vol.53 número9

... fferentiated thyroid cancer (49), using a dose of 125 mg administered orally once ...(61%) of whom had papillary thyroid carcinoma and 32 (34%) follicular thyroid car- ... See full document

13

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer

... trial of lenvatinib in RAI-refractory DTC led to complete response in 15% and partial response in 63% of treated ...response with lenvatinib was only 2 months ...therapy ... See full document

6

Arq Bras Endocrinol Metab  vol.57 número9

Arq Bras Endocrinol Metab vol.57 número9

... frequency of thyroid cancer in acromegalic patients was ...three patients had not yet undergo­ ne surgery. This frequency is approximately 300 times higher than the ... See full document

6

Prevalence	of	BRAF	Mutation	in	Papillary	Thyroid	Cancer

Prevalence of BRAF Mutation in Papillary Thyroid Cancer

... 85% of all thyroid malignancies [2]. Although PTC is considered to be a curable disease with a 10-year-survival rate of more than 90%, disease recurrence is quite common, and a ... See full document

7

Profile of thyroid hormones in breast cancer patients

Profile of thyroid hormones in breast cancer patients

... performed in order to confirm the previous ...absence of breast cancer. These mammograms were performed in the same week when anamnesis and blood samples were ...difference in E 2 ... See full document

5

Arq. Gastroenterol.  vol.46 número2

Arq. Gastroenterol. vol.46 número2

... Most of the studies conducted on CTC have compared it to colonoscopy for the detection of polyps and colorectal ...cancer. In a study performed with 1,233 asymptomatic patients, ... See full document

7

Hyponatremia after Thyroid Hormone Withdrawal in a Patient with Papillary Thyroid Carcinoma

Hyponatremia after Thyroid Hormone Withdrawal in a Patient with Papillary Thyroid Carcinoma

... Hyponatremia is an electrolyte abnormality commonly found in clinical ...It is important to diagnose the underlying etiol- ogy of the hyponatremia and correct it appropriately because severe ... See full document

6

Papillary thyroid microcarcinoma in a thyroid pyramidal lobe

Papillary thyroid microcarcinoma in a thyroid pyramidal lobe

... The thyroid gland is one of the largest endocrine gland, and comprises two lateral lobes that are connected along the median line by an isthmus, as well as the TPL, which extends superiorly from the ... See full document

4

Oxifilia nas lesões nodulares da tireóide: classificação e relação com marcadores...

Oxifilia nas lesões nodulares da tireóide: classificação e relação com marcadores...

... composed of 134 tumours from 125 patients (ten additional tumours were excluded for technical ...files of Hospital de S Jo˜ao/Medical Faculty of Porto, Portugal; IPATIMUP, Porto, Portugal; ... See full document

181

Outcomes of patients with bone metastases from differentiated thyroid cancer

Outcomes of patients with bone metastases from differentiated thyroid cancer

... differentiated thyroid cancer (DTC) are associated with poor survival ...frequency of this entity, we performed a multicentric retrospective study that aimed to evaluate the presentation, ... See full document

7

Arq Bras Endocrinol Metab  vol.52 número8

Arq Bras Endocrinol Metab vol.52 número8

... forms of multiple endocrine neoplasia of dominant autosomal ...nosis of CNC occurs when two major criteria (lentiginoses, primary pigmented nodular adrenocortical disease, cardiac and cutaneous ... See full document

6

Identificação de microRNAs associados com recidiva em carcinoma papilífero da ti...

Identificação de microRNAs associados com recidiva em carcinoma papilífero da ti...

... presence of cervical lymph node metastasis and histological ...associated with recurrence. Expression levels of miR-9 and miR-21 were significantly lower in the recurrent group than in ... See full document

140

Show all 10000 documents...